Basic information Safety Supplier Related

BREVISCAPIN

Basic information Safety Supplier Related

BREVISCAPIN Basic information

Product Name:
BREVISCAPIN
Synonyms:
  • 5,6-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl--D-glucopyranosiduronic acid hydrate
  • 7-(β-D-Glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one hydrate
  • BREVISCAPIN
  • A natural extract containing apigenin 7-glucuronide and scutellarein 7-glucuronide
  • Scutellarin hydrate
  • Breviscapine,Erigeron Breviscapus
  • Lamps,
  • (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylicaci
CAS:
116122-36-2
MF:
C21H18O11.C21H18O12
MW:
908.723
Mol File:
116122-36-2.mol
More
Less

BREVISCAPIN Chemical Properties

storage temp. 
2-8°C
form 
Solid
color 
Light yellow to yellow
InChIKey
BYTLLPAZARDJBB-MKCAKFMMNA-N
LogP
0.426 (est)
More
Less

BREVISCAPIN Usage And Synthesis

Uses

Breviscapine is a crude flavonoid extract of Breviscapine, which is more than 85% of the active ingredient, Breviscapine. Breviscapine has a wide range of cardiovascular pharmacological activities, such as increasing blood flow, improving microcirculation, dilating blood vessels, reducing blood viscosity, promoting fibrinolysis, inhibiting platelet aggregation and thrombosis. Breviscapine has been used in the study of cerebral infarction and its sequelae, cerebral thrombosis, coronary heart disease and angina pectoris[1][2].

Definition

ChEBI: Scutellarin is the glycosyloxyflavone which is the 7-O-glucuronide of scutellarein. It has a role as an antineoplastic agent and a proteasome inhibitor. It is a glycosyloxyflavone, a glucosiduronic acid, a trihydroxyflavone and a monosaccharide derivative. It is functionally related to a scutellarein. It is a conjugate acid of a scutellarin(1-).

References

[1] Gao J, et al. Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review. Front Pharmacol. 2017 May 23;8:289. DOI:10.3389/fphar.2017.00289
[2] Wen L, et al. Breviscapine: A Review on its Phytochemistry, Pharmacokinetics and Therapeutic Effects. Am J Chin Med. 2021;49(6):1369-1397. DOI:10.1142/S0192415X21500646

BREVISCAPINSupplier

Nanjing bingcheng Biotechnology Co., Ltd. Gold
Tel
18805194892
Email
2727751293@qq.com
Shandong Xiya Chemical Co., Ltd
Tel
4009903999 13355009207
Email
3007715519@qq.com
ALB Technology Limited
Tel
702-983-3769
Email
sales@albtechnology.com
Wuhan ChemFaces Biochemical Co., Ltd.
Tel
18607101326 15172504745
Email
aileen@chemfaces.com
EMMX Biotechnology LLC
Tel
888-539-0666
Email
info@emmx.com